Stockscreener 앱 받기
3.20
0.00%
0.00
전일 마감가:
$3.20
열려 있는:
$3.25
하루 거래량:
15,194
Relative Volume:
0.33
시가총액:
$10.17M
수익:
-
순이익/손실:
$-7.29M
주가수익비율:
-0.1313
EPS:
-24.3686
순현금흐름:
$-6.81M
1주 성능:
-2.44%
1개월 성능:
+38.53%
6개월 성능:
-18.99%
1년 성능:
-3.76%
1일 변동 폭
$3.1325
$3.25
1주일 범위
$3.02
$3.33
52주 변동 폭
$2.01
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
명칭
Heartsciences Inc
전화
682-237-7781
주소
550 RESERVE ST, SUITE 360, SOUTHLAKE
HSCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.20 | 10.17M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Heartsciences Inc 주식(HSCS)의 최신 뉴스
HeartSciences Secures New Private Financing Through Note Issuance - TipRanks
HeartSciences Signs Note Purchase Agreement With Streeterville Capital - TradingView — Track All Markets
Trend Report: How HeartSciences Inc Equity Warrant stock reacts to oil pricesJuly 2025 Reactions & Real-Time Chart Breakout Alerts - Bộ Nội Vụ
Will HeartSciences Inc. Equity Warrant stock recover faster than peersJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - Улправда
Why hedge funds are buying HeartSciences Inc. Equity Warrant stockWeekly Profit Report & Fast Momentum Stock Entry Tips - Улправда
What hedge fund activity signals for HeartSciences Inc. Equity Warrant stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - Улправда
Why HeartSciences Inc. Equity Warrant stock remains resilientMarket Performance Recap & High Return Trade Opportunity Guides - ulpravda.ru
Why HeartSciences Inc. Equity Warrant stock appeals to dividend seekersJuly 2025 News Drivers & Scalable Portfolio Growth Methods - Улправда
Can HeartSciences Inc. stock deliver sustainable ROEWeekly Earnings Recap & Growth Focused Entry Point Reports - Улправда
Will HeartSciences Inc. stock recover faster than peers2025 Sector Review & Momentum Based Trading Signals - Улправда
Is HeartSciences Inc. stock a safe haven asset2025 Volatility Report & Fast Gaining Stock Reports - Улправда
Buyout Rumor: Why HeartSciences Inc. Equity Warrant stock remains resilientJuly 2025 Chart Watch & High Conviction Buy Zone Picks - ulpravda.ru
Published on: 2026-01-12 22:13:00 - ulpravda.ru
Is HeartSciences Inc. Equity Warrant stock supported by strong cash flows2026 world cup usa national team group stage defensive leaders transition play odds analysis expert opinion - Улправда
What analysts say about HeartSciences Inc Equity Warrant stockMarket Depth Overview & Free Technical Analysis and Insights - Early Times
Market Meltdown the Virus and our ActionablesStock Price Divergence & Affordable Trading Strategies - bollywoodhelpline.com
Indo Count Industries Limited (ICIL) Expands into New MarketPrice-to-Book Ratio Updates & Exceptional Capital Growth - bollywoodhelpline.com
HeartSciences (NASDAQ:HSCS) Price Target Raised to $9.20 at Ascendiant Capital Markets - Defense World
HeartSciences (NASDAQ:HSCS) and Movano (NASDAQ:MOVE) Critical Survey - Defense World
Ascendiant Capital Maintains HeartSciences (HSCS) Buy Recommendation - Nasdaq
HeartSciences (HSCS) Receives Updated Analyst Rating and Price T - GuruFocus
HeartSciences (NASDAQ:HSCS) & Health Catalyst (NASDAQ:HCAT) Critical Analysis - Defense World
Does HeartSciences Inc. stock trade at a discount to peersJuly 2025 Spike Watch & Verified Swing Trading Watchlists - Улправда
Is HeartSciences Inc. Equity Warrant stock a top pick in earnings seasonEarnings Recap Report & Low Risk High Reward Ideas - Улправда
Why HeartSciences Inc. Equity Warrant stock could see breakout soon2025 Sector Review & Fast Entry High Yield Tips - Улправда
Will HeartSciences Inc. Equity Warrant stock attract ESG investorsMarket Weekly Review & Long Hold Capital Preservation Plans - Улправда
Will HeartSciences Inc. Equity Warrant stock deliver shareholder valueJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - Улправда
History Review: Does HeartSciences Inc. stock trade at a discount to peers2025 Major Catalysts & Real-Time Volume Triggers - Улправда
HeartSciences Submits MyoVista wavECG Device for FDA Clearance - Diagnostic and Interventional Cardiology
HeartSciences approves indemnification agreements for directors and officers By Investing.com - Investing.com Nigeria
HeartSciences approves indemnification agreements for directors and officers - Investing.com
Heart Test Laboratories Approves Indemnification Agreement - TipRanks
HeartSciences reports no meaningful revenue in Q2 2026 - Medical Buyer
HeartSciences Inc. Reports Second Quarter Fiscal 2026 Financial Results and Progress on MyoVista Insights and wavECG Device Submissions - Quiver Quantitative
HeartSciences (Nasdaq: HSCS) Q2 shows $2M cash, MyoVista Insights push - Stock Titan
HeartSciences (NASDAQ: HSCS) posts loss, highlights going concern and new funding - Stock Titan
HeartSciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025 - marketscreener.com
HeartSciences files FDA 510(k) for MyoVista WaveCG device - marketscreener.com
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device - The Manila Times
Daily News - FinancialContent
HeartSciences Inc. Announces Commercial Release of MyoVista Insights™ Version 1.1 Enhancing ECG System Capabilities - Quiver Quantitative
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with ... - Enidnews.com
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 - The Manila Times
HeartSciences Announces Major Upgrade to User Features of - GlobeNewswire
Gross profit of HeartSciences Inc. from 2021 to 2024 - Statista
HeartSciences (HSCS) to Release Quarterly Earnings on Monday - Defense World
Reviewing Hims & Hers Health (NYSE:HIMS) and HeartSciences (NASDAQ:HSCS) - Defense World
S&P 500, NASDAQ and Dow continue upward trend as Wall Street rises to the edge of its all-time high; Treas - The Economic Times
Risk Off: Why MLPR stock is seen as undervaluedPrice Action & Expert-Curated Trade Recommendations - BỘ NỘI VỤ
How HeartSciences Inc. Equity Warrant stock performs in rate cut cyclesJuly 2025 Levels & Weekly Return Optimization Alerts - Newser
HeartSciences (HSCSW) Stock Analysis Report | Financials & Insights - Benzinga
Heartsciences Inc (HSCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):